Trial Profile
A Phase I, open-label, 2-way crossover study to assess the effect of food on the bioavailability and tolerability of Mirogabalin in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Nov 2016
Price :
$35
*
At a glance
- Drugs Mirogabalin (Primary)
- Indications Fibromyalgia; Neuropathic pain; Postherpetic neuralgia
- Focus Pharmacokinetics
- 20 Nov 2016 New trial record
- 30 Sep 2016 Results presented at the 16th World Congress on Pain